Tarsons Products has notified the stock exchanges of an upcoming Board of Directors meeting, scheduled for Friday, May 22, 2026. The intimation, dated May 18, 2026, was filed pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Board Meeting Details

The meeting has been convened to consider and approve the audited standalone and consolidated financial results for the quarter and financial year ended March 31, 2026. The board will also take up the Audit Report of the Statutory Auditors for the corresponding period, along with any other business matters as applicable.

Key details of the scheduled board meeting are outlined below:

Trading Window Closure

In connection with the board meeting, Tarsons Products has also informed the exchanges regarding the Trading Window closure. Referencing its earlier Trading Window Closure intimation dated March 24, 2026, the company has stated that the Trading Window for dealing in the securities of the company by its designated persons shall remain closed up to 48 hours after the declaration of the financial results.

The intimation was signed by Santosh Kumar Agarwal, CFO, Company Secretary & Compliance Officer (ICSI Membership No. A44836), on behalf of Tarsons Products.

Tarsons Products Limited has announced a key senior management appointment, naming Mr. Mani Kalyan Dusi as Head-Revenue (India & APAC) in the Senior Management Personnel category. The appointment, disclosed to stock exchanges on April 14, 2026, under Regulation 30 of SEBI Listing Regulations, reflects the company's strategic focus on strengthening its leadership team in key growth markets.

Appointment Details and Timeline

The Board of Directors approved Mr. Dusi's appointment based on the recommendation of the Nomination & Remuneration Committee. He is expected to join the company on or before May 20, 2026, taking on the critical role of driving revenue operations across India and the Asia-Pacific region.

Professional Background and Expertise

Mr. Mani Kalyan Dusi brings over 18 years of extensive experience in the life sciences, pharmaceuticals, and academic sectors across the APAC region. His professional expertise encompasses commercial leadership, strategic marketing, go-to-market strategies, and P&L management, with a demonstrated track record of driving business growth and operational excellence.

Currently serving as Associate Director and Head – Commercial Enablement (APAC) at Merck Life Science, he leads regional strategy and business development initiatives. His career includes key leadership roles at both Merck Life Science and Thermo-Fisher Scientific, where he successfully managed large portfolios, led cross-functional teams, and strengthened customer-centric innovation and market expansion efforts.

Key Qualifications and Achievements

Mr. Dusi is recognized for his data-driven approach, digital enablement capabilities, and ability to build high-performing teams. His professional accomplishments include:

• Receipt of the AAA Award for marketing leadership at Merck
• Active contribution to diversity, equity, and inclusion (DEI) initiatives
• M.Sc. in Biochemistry (University First Rank) from Andhra University
• Executive leadership education completion at INSEAD

Strategic Implications

The appointment of Mr. Dusi as Head-Revenue for India & APAC underscores Tarsons Products' commitment to strengthening its commercial operations in key growth markets. His extensive experience in the life sciences sector and proven expertise in regional strategy development align with the company's operational focus in laboratory and scientific equipment manufacturing.

The disclosure was made in compliance with SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026, ensuring transparency in senior management changes for stakeholders and regulatory authorities.